DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+CD15− cells in early chronic‐phase chronic myeloid leukemia. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.